Serum bicarbonate level also did not appear to affect the accuracy of real-time continuous glucose monitoring (rtCGM) in pediatric diabetic ketoacidosis (DKA).
The use of real-time continuous glucose monitoring (rtCGM) in managing diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1D) is both feasible and accurate, according to research published in Journal of Diabetes Science and Technology.
According to the authors, serum bicarbonate level did not seem to affect rtCGM accuracy in the setting of DKA, but further research assessing the use and cost-effectiveness of rtCGM in treatment decisions is necessary. While the use of rtCGM in ambulatory settings has been shown to improve overall glycemic control and reduce DKA incidence in both adults and children with T1D, its use in children with DKA has not been well researched, they added.
The prospective, single-arm, single-center study included data from 35 children hospitalized with DKA, with a mean (SD) age of 11.9 (4.1) years.
Accuracy, reliability, and feasibility of a commercially available rtCGM device was compared with that of point-of-care (POC) capillary and serum glucose values in these pediatric patients and was evaluated by Clarke Error Grid (CEG) analysis. Average length of hospital stay (LOS) and the relationship between rtCGM readings and degree of acidosis were also assessed.
Among the 35 children in the study, the authors collected 524 time-matched glucose values between serum glucose and rtCGM and 91 time-matched glucose values between POC capillary glucose and rtCGM. CEG analysis showed more than 95% of each of these pairs were clinically acceptable.
The average (SD) LOS was 1.32 (0.73 days).
When compared with serum bicarbonate level, there was a negative correlation (−0.27) between serum glucose and rtCGM delta (P < .01), but a positive correlation between POC capillary glucose and rtCGM delta (P = .06).
“Analyses of serum bicarbonate levels demonstrated that the degree of acidosis and impaired perfusion during an episode of DKA does not impact the accuracy or reliability of rtCGM values,” the authors noted.
They also measured a mean duration of rtCGM use of 18.6 (9.7) hours, correlating to more than 18 fingerstick POC tests that may not have been needed if rtCGM data were used to make treatment decisions.
No adverse events were reported. However, the authors noted multiple limitations, including time delays between DKA diagnosis and rtCGM readings and the lack of patients presenting extreme acidosis or hyperglycemia
“These extremes are the factors that are of most clinical interest because the functionality and accuracy of rtCGM are potentially most affected within these extreme ranges,” the authors noted. “A final limitation was the inability to provide a blinded evaluation; however, because the study protocol prohibited nursing staff and physicians to act upon the results of the rtCGM, we do not feel this impacted our findings.”
Reference
Pott T, Jimenez-Vega J, Parker J, Fitzgerald R. Continuous glucose monitoring in pediatric diabetic ketoacidosis. J Diabetes Sci Technol. Published online November 23, 2022. doi:10.1177/19322968221140430
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen